Biogen Inc. (BIIB)
NASDAQ·Healthcare·Drug Manufacturers - General
$206.75
+3.39%
Mkt Cap $29.85B
Analyst Ratings
Buy
22
Hold
17
Sell
0
Price Target (129 analysts)
$218.32
Range $185.00 – $260.00
Implied Upside
+5.6%
Consensus $218.32 vs current $206.75